Avidity Biosciences, Inc.

RNA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$350,158$243,907$254,203$219,868
Short-Term Investments$1,525,678$939,237$1,125,674$1,281,629
Receivables$15,037$8,540$36,582$28,222
Inventory$0$0$0$0
Other Curr. Assets$59,992$58,876$0$0
Total Curr. Assets$1,966,017$1,250,560$1,434,975$1,542,290
Property Plant & Equip (Net)$74,352$24,762$20,566$18,289
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$2,798$0$0
Tax Assets$0$0$0$0
Other NC Assets$93,840$90,806$3,534$3,316
Total NC Assets$168,192$118,366$24,100$21,605
Other Assets$0$0$0$0
Total Assets$2,134,209$1,368,926$1,459,075$1,563,895
Liabilities
Payables$9,626$3,914$6,633$8,461
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$19,123$13,537$13,978$20,987
Other Curr. Liab.$37,085$95,236$12,814$3,663
Total Curr. Liab.$169,879$135,061$84,865$98,018
LT Debt$0$0$0$0
Deferred Rev, NC$32,066$39,991$43,397$37,961
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$78,065$41,201$45,487$40,918
Other Liabilities$0$0$0$0
Cap. Leases$49,966$5,135$5,974$6,801
Total Liabilities$247,944$176,262$130,352$138,936
Equity
Pref Stock$0$0$0$0
Common Stock$15$12$12$12
Retained Earnings-$1,340,596-$1,166,154-$1,008,839-$893,066
AOCI$1,768$1,777$2,766$2,902
Other Equity$0$0$0$0
Total Equity$1,886,265$1,192,664$1,328,723$1,424,959
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$2,134,209$1,368,926$1,459,075$1,563,895
Net Debt-$350,158-$243,907-$254,203-$219,868